Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetic Characterization of Intramuscular Olanzapine Depot

Trial Profile

Pharmacokinetic Characterization of Intramuscular Olanzapine Depot

Phase of Trial: Phase I/II

Latest Information Update: 08 Aug 2006

At a glance

  • Drugs Olanzapine (Primary)
  • Indications Schizoaffective disorder; Schizophrenia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 08 Aug 2006 Status change
    • 09 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top